Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
HONG KONG, Aug. 9, 2021 /PRNewswire/ — Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine’s AI-augmented platforms and close cooperation between Arvinas’ and Insilico Medicine’s scientists on…
Comments Off on
Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas